Durata off premarket

Shares of Durata Therapeutics (DRTX) are off 23% premarket on modest volume in apparent profit-taking after the pre-Dalvance approval run-up over the past 30 days when shares popped ~45% from the April 14 low of $11.68.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs